Literature DB >> 12677464

Persistent left superior vena cava: a reason for pseudodisplacement of a port catheter.

L Schiffmann1, M Kruschewski, F Wacker, H J Buhr.   

Abstract

Port catheters have been increasingly used in recent years. Using one case as an example, we demonstrate how an anatomic variation can easily become a pitfall when inserting a central venous catheter, port catheter, pacemaker or Swan-Ganz catheter. We report a case of persistent left superior vena cava, the most common variation in the thoracic venous system. Since these procedures are increasingly being performed, surgeons, anesthesiologists and radiologists should be aware of the possible anatomic variations.

Mesh:

Year:  2003        PMID: 12677464     DOI: 10.1007/s00276-002-0088-4

Source DB:  PubMed          Journal:  Surg Radiol Anat        ISSN: 0930-1038            Impact factor:   1.246


  12 in total

1.  [A new technique for implantation of venous port systems].

Authors:  M Probst; D Jooss; F Salomon
Journal:  Chirurg       Date:  1996-05       Impact factor: 0.955

2.  Left superior vena cava continuing to the accessory hemiazygos without anastomosis with the coronary sinus.

Authors:  H Sakamoto; K Akita; K Sato; T Sato
Journal:  Surg Radiol Anat       Date:  1993       Impact factor: 1.246

3.  Central venous catheterization via persistent left superior vena cava.

Authors:  R K Josloff; J S Kukora
Journal:  Am Surg       Date:  1995-09       Impact factor: 0.688

4.  The acute toxicities of chemotherapy.

Authors:  R J Spiegel
Journal:  Cancer Treat Rev       Date:  1981-09       Impact factor: 12.111

5.  Totally implanted system for intravenous chemotherapy in patients with cancer.

Authors:  J Gyves; W Ensminger; J Niederhuber; M Liepman; E Cozzi; K Doan; S Dakhil; R Wheeler
Journal:  Am J Med       Date:  1982-12       Impact factor: 4.965

6.  A totally implanted injection port system for blood sampling and chemotherapy administration.

Authors:  J W Gyves; W D Ensminger; J E Niederhuber; T Dent; S Walker; S Gilbertson; E Cozzi; P Saran
Journal:  JAMA       Date:  1984-05-18       Impact factor: 56.272

7.  Implantable central venous access system.

Authors:  A Bothe; W Piccione; J J Ambrosino; P N Benotti; J J Lokich
Journal:  Am J Surg       Date:  1984-04       Impact factor: 2.565

8.  Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole.

Authors:  C U Ludwig; H R Stoll; R Obrist; J P Obrecht
Journal:  Eur J Cancer Clin Oncol       Date:  1987-03

9.  [Implantable catheter systems. Experiences with 1000 patients with central venous ports].

Authors:  H J Kock; U Krause; M Pietsch; S Rasfeld; M K Walz
Journal:  Dtsch Med Wochenschr       Date:  1996-01-19       Impact factor: 0.628

10.  Improved methods for venous access: the Port-A-Cath, a totally implanted catheter system.

Authors:  S Strum; J McDermed; A Korn; C Joseph
Journal:  J Clin Oncol       Date:  1986-04       Impact factor: 44.544

View more
  3 in total

1.  Successful percutaneous cardiac resynchronization despite an occlusive Thebesian valve.

Authors:  Milind G Parikh; Sean M Halleran; Saroja Bharati; Richard G Trohman
Journal:  Pediatr Cardiol       Date:  2011-07-31       Impact factor: 1.655

Review 2.  Persistent left superior vena cava: review of the literature, clinical implications, and relevance of alterations in thoracic central venous anatomy as pertaining to the general principles of central venous access device placement and venography in cancer patients.

Authors:  Stephen P Povoski; Hooman Khabiri
Journal:  World J Surg Oncol       Date:  2011-12-28       Impact factor: 2.754

3.  Persistent left superior vena cava detected after central venous catheter insertion.

Authors:  Jan M Sohns; Martin Fasshauer; Wieland Staab; Michael Steinmetz; Christina Unterberg-Buchwald; Jan Menke; Joachim Lotz
Journal:  Springerplus       Date:  2014-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.